Susquehanna Fundamental Investments LLC Makes New $1.38 Million Investment in LifeStance Health Group, Inc. (NASDAQ:LFST)

Susquehanna Fundamental Investments LLC bought a new position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 186,781 shares of the company's stock, valued at approximately $1,377,000.

Other institutional investors also recently modified their holdings of the company. Blue Trust Inc. increased its stake in LifeStance Health Group by 124.4% during the fourth quarter. Blue Trust Inc. now owns 3,828 shares of the company's stock valued at $27,000 after acquiring an additional 2,122 shares during the period. R Squared Ltd acquired a new stake in LifeStance Health Group in the 4th quarter valued at $80,000. Cibc World Markets Corp bought a new stake in LifeStance Health Group in the fourth quarter valued at $96,000. Forum Financial Management LP acquired a new position in LifeStance Health Group during the fourth quarter worth $110,000. Finally, Handelsbanken Fonder AB acquired a new position in LifeStance Health Group during the fourth quarter worth $128,000. Institutional investors own 85.50% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on LFST. Canaccord Genuity Group assumed coverage on shares of LifeStance Health Group in a report on Thursday, April 3rd. They issued a "buy" rating and a $8.00 target price on the stock. KeyCorp began coverage on shares of LifeStance Health Group in a research note on Tuesday, April 8th. They set an "overweight" rating and a $9.00 price objective on the stock. Finally, William Blair reiterated an "outperform" rating on shares of LifeStance Health Group in a research note on Friday, February 28th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $8.30.

LifeStance Health Group Price Performance

LFST traded down $0.18 during midday trading on Monday, hitting $6.62. The company had a trading volume of 1,227,913 shares, compared to its average volume of 1,621,192. LifeStance Health Group, Inc. has a twelve month low of $4.64 and a twelve month high of $8.61. The company has a market capitalization of $2.57 billion, a PE ratio of -25.46 and a beta of 1.30. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32. The firm's 50-day simple moving average is $6.88 and its 200-day simple moving average is $7.29.

Insider Activity

In related news, insider Lisa K. Miller sold 18,845 shares of the firm's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $6.90, for a total value of $130,030.50. Following the transaction, the insider now owns 339,810 shares in the company, valued at $2,344,689. This trade represents a 5.25 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 6.60% of the stock is owned by insiders.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.